ABBV
AbbVie Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$263.78
−0.09%Forward multiples
Based on analyst estimates
- P/E forward
- 17.36x
- P/E 2026E
- 18.77x
- P/E 2027E
- 16.11x
- P/E 2028E
- 14.71x
- P/S forward
- 6.66x
Trailing multiples
Trailing twelve months
- P/E TTM
- 74.31x
- PEG TTM
- 0.23x
- Price / book
- -78.54x
- Price / sales
- 7.24x
- Price / cash flow
- 23.90x
Enterprise value
- Enterprise value
- $530.4B
- EV / sales
- 8.24x
- EV / EBITDA
- 24.98x
- EV / EBIT
- 28.10x
- Market cap
- $466.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026